Gaviscon (Alumina & Magnesium Trisilicate) Regular Strength Original Flavor Chewable Tablets, 80 mg & 14.2 mg, 100-count bottles, Distributed by: GlaxoSmithKline Consumer Healthcare, L.P., Moon Twp, PA 15108, UPC 3 0088-1175-47 8.
Published July 5, 2017 · Recall initiated: June 12, 2017
Summary
FDA records drug Class III recall D-0926-2017, published July 5, 2017 and initiated June 12, 2017. Recalling firm: Sanofi-Aventis U.S. LLC; Status: Terminated; Reported quantity: 2980 bottles; Lot: Lot #: 5J69A, Exp 02/19; 6GF2A, 6GF3A, Exp 08/19. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Superpotent Drug: high out-of-specification result for magnesium.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Sanofi-Aventis U.S. LLC
- Distributor
- Nationwide in the USA, Puerto Rico, and the United Kingdom.
- Lot
- Lot #: 5J69A, Exp 02/19; 6GF2A, 6GF3A, Exp 08/19
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAAdmelog, insulin lispro injection, 100 units/mL (U-100), 3mL multi-dose vial, Rx Only, Sanofi-Aventis U.S.May 24, 2023
- FDAElitek (rasburicase) for injection, 7.5 mg vial, Rx Only Mfd. by Sanofi - Aventis U. S. LLC Bridgewater, NJ,August 26, 2020
- FDACool Mint Tablets Maximum Strength Zantac 150 mg Sanofi Distributed by: Chattem, Inc., a Sanofi Company P.O.December 11, 2019
- FDARegular Strength Zantac 75 mg, Distributed by: Chattem, Inc., a Sanofi Company P.O. Box 2219, Chattanooga, TNDecember 11, 2019
- FDAWalgreens Daytime and Nighttime Cold & Flu, packaged in combo pack of two plastic 12FL OZ (355 mL) bottlesJuly 5, 2017
- FDADoxycycline Hyclate USP, active pharmaceutical ingredient, a) 25 g packaged in a 500 cc container (NDC:July 5, 2017
Questions about this recall
Was Gaviscon (Alumina & Magnesium Trisilicate) Regular Strength Original Flavor Chewable Tablets, 80 mg & 14.2 mg, 100-count bottles, Distributed by: GlaxoSmithKline Consumer Healthcare, L.P., Moon Twp, PA 15108, UPC 3 0088-1175-47 8. recalled?
Yes. FDA published recall D-0926-2017 on July 5, 2017. Reported hazard: Superpotent Drug: high out-of-specification result for magnesium.
What should I do if I have this product?
Voluntary: Firm initiated · Letter